Uso Inyectable
Highlights Globally, HF remains a leading cause of death, disability, and health care expenditures, but practice patterns may differ internationally
In the SURPASS trial data, acute pancreatitis occurred at approximately 0.23 events per 100 person-years with tirzepatide versus 0.11 with comparators roughly double the comparator rate in the controlled T2D trials, but small in absolute terms for most people
It notes that the benefit of a dual agonist depends partly on GIP receptor function, so the second pathway is not a uniform bonus for everyone
The timeline for starting a GLP-1 after weaning depends on a few factors, including how recently you delivered, how your recovery is going, whether your postpartum hormones have stabilized, and whether you meet the clinical criteria for a GLP-1 prescription